CLAYTON, N.C. (WTVD) -- A company that makes medicines for chronic diseases announced it will be investing $4.1 billion to build a new facility in Clayton.
The company is called Novo Nordisk and it already has three manufacturing facilities in the Triangle -- one in Durham and two in Clayton.
The investment marks the largest single life science investment in North Carolina history. It tops the $1.8 billion investment announcement in 2016 from Novo Nordisk for one of its facilities in Clayton.
"Novo Nordisk's decision to expand its manufacturing capability with a multi-billion-dollar investment is testament to North Carolina's top-notch workforce and long history of being a leader in the life sciences and biopharmaceutical industries," said Christopher Chung, CEO of the Economic Development Partnership of North Carolina. "This announcement is the largest life sciences investment in the state's history, and we are proud that Novo Nordisk has confidence in the workforce, resources and partnerships North Carolina provides."
The medical company already employs more than 2,500 North Carolinians. This new facility in Clayton will create another 1,000 jobs. Plus, the construction phase of the project will create an estimated 2,000 contractor jobs.
The new facility will be 1.4 million square feet. It will be used to create and package medications for things like obesity and other chronic diseases. This new facility will be nearly four times as large as the original Clayton facility, which is located across the street.
Construction is already underway for the project. Novo Nordisk said it expects major phases of the construction to be completed between 2027 and 2029.
ABC11's Michael Perchick was at the announcement Monday. He will have a full report tonight on what this means for people in the area and the local economy.
Copyright © 2024 WTVD-TV. All Rights Reserved.
Read Again https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vYWJjMTEuY29tL3Bvc3Qvbm92by1ub3JkaXNrLWNyZWF0ZS0xMDAwLW5ldy1qb2JzLWludmVzdC00MWIvMTQ5OTYxMDUv0gEA?oc=5Bagikan Berita Ini
0 Response to "Novo Nordisk plans $4.1B investment to create new medicine manufacturing facility in Clayton - WTVD-TV"
Post a Comment